Stephen M Katz
Overview
Explore the profile of Stephen M Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knight R, Podder H, Kerman R, Lawless A, Katz S, Van Buren C, et al.
Transplantation
. 2010 Mar;
89(6):727-32.
PMID: 20195219
Aim: A prednisone and calcineurin inhibitor (CNI)-free protocol was compared with a sirolimus, cyclosporine A (CsA), and prednisone-based immunosuppressive regimen for simultaneous pancreas-kidney transplantation (SPK). Methods: A nonrandomized, single-center, sequential...
2.
Knight R, Villa M, Laskey R, Benavides C, Schoenberg L, Welsh M, et al.
Clin Transplant
. 2007 Jul;
21(4):460-5.
PMID: 17645704
Aim: As sirolimus has been implicated in impaired wound healing, the aim of this study was to evaluate risk factors for wound complications after renal transplantation in patients treated with...
3.
Stepkowski S, Phan T, Zhang H, Bilinski S, Kloc M, Qi Y, et al.
Transplantation
. 2007 Jan;
82(12):1756-63.
PMID: 17198272
Background: Previously we showed that pancreatic islets cultured for seven days in rotating bioreactors survived for >100 days in allogeneic recipients without immunosuppression. This survival coincided with almost complete elimination...
4.
Csapo Z, Knight R, Podder H, Kerman R, Schoenberg L, Katz S, et al.
Clin Transplant
. 2006 Jul;
20(4):423-6.
PMID: 16842516
Aim: To compare the outcomes of single paediatric vs. adult kidneys transplanted into adult recipients. Methods: A retrospective single-centre review of 38 single cadaver kidney transplants from donors less than...
5.
Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu Y, et al.
Transplantation
. 2005 Oct;
80(7):910-6.
PMID: 16249738
Background: Monitoring cyclosporine microemulsion (CsA-ME; Neoral) exposure 2 hours postdose (C2) has been reported to optimize the efficacy and safety of CsA-ME therapy. The addition of induction therapy to a...
6.
Kahan B, Yakupoglu Y, Schoenberg L, Knight R, Katz S, Lai D, et al.
Transplantation
. 2005 Oct;
80(6):749-58.
PMID: 16210961
Background: Malignancies, a well-known complication of immunosuppressive therapy in renal transplant recipients, represent an important cause of long-term morbidity and mortality. One approach to addressing this problem is identifying agents...
7.
Rutzky L, Bilinski S, Kloc M, Phan T, Zhang H, Katz S, et al.
Transplantation
. 2002 Jul;
74(1):13-21.
PMID: 12134093
Background: The failure of pancreatic islet allotransplants observed in almost all clinical attempts is related to poor initial islet function and allograft rejection. To remedy these problems we cultured islets...
8.
Langer R, Van Buren C, Katz S, Kahan B
Transplantation
. 2002 Mar;
73(5):756-60.
PMID: 11907423
Objective: We sought to examine factors that predisposed 1.5% (10/672) of renal transplant recipients treated with a cyclosporine (CsA)/sirolimus (SRL)/steroid immunosuppressive regimen to develop hemolytic uremic syndrome (HUS). Methods: Two...
9.
Kahan B, Welsh M, Urbauer D, Mosheim M, Beusterien K, Wood M, et al.
J Am Soc Nephrol
. 2000 May;
11(6):1122-1131.
PMID: 10820177
The present study applied a receiver operating characteristic (ROC) analysis to assess the role of intraindividual variability of cyclosporin A (CsA) drug exposure in predisposing renal transplant recipients to the...